Bioelectronics Corp (BIEL)

[GetSeriousOK]

No, Full clearance will cause a PPS spike.

Furthermore, the stock currently has a value of .0007 per share. It is not "ZERO" and it's never going to be "ZERO."

This company could survive forever as a pinksheet non-reporting developmental biotech. The question is whether or not the new management will figure out a way to sell the device in the USA after full OTC clearance. I think the main problem is obvious: $30 - $35 is too high a price. They need to design a $14.99 device that lasts two weeks or pamybe a $19.99 device that lasts 20 days -- the consumer needs to spend $20 and walk away with the device. Simple microeconomics.